The first GIPR KO mouse characterized, with deletion of exon 45, showed decreased bone formation parameters such as aBMD, bone mineral content (BMC), trabecular bone volume, ALP and osteocalcin, and increased resorptive parameters, such as increased numbers of osteoclasts and increased urinary elimination of the resorption marker, deoxypyridinoline (24, 25)
For vial-based microdosing, concentration matters more than vial size
Dermatologic reactions linked to GLP-1 therapy are gaining attention as the use of glucagon-like peptide-1 receptor agonists continues to expand in diabetes and obesity care
Alcohol use disorder (AUD) A random-effects meta-analysis of three studies [25,26,27] demonstrated that GLP-1RA use was associated with a significantly lower risk of AUD diagnosis compared with nonGLP-1RA comparators (HR = 0.72, 95% CI: 0.590.89, p = 0.0019)
That albumin binding is why you only need one injection per week instead of multiple daily doses